These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 28613873)

  • 1. The Drug-Resistant Variant P167S Expands the Substrate Profile of CTX-M β-Lactamases for Oxyimino-Cephalosporin Antibiotics by Enlarging the Active Site upon Acylation.
    Patel MP; Hu L; Stojanoski V; Sankaran B; Prasad BVV; Palzkill T
    Biochemistry; 2017 Jul; 56(27):3443-3453. PubMed ID: 28613873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonism between substitutions in β-lactamase explains a path not taken in the evolution of bacterial drug resistance.
    Brown CA; Hu L; Sun Z; Patel MP; Singh S; Porter JR; Sankaran B; Prasad BVV; Bowman GR; Palzkill T
    J Biol Chem; 2020 May; 295(21):7376-7390. PubMed ID: 32299911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A triple mutant in the Ω-loop of TEM-1 β-lactamase changes the substrate profile via a large conformational change and an altered general base for catalysis.
    Stojanoski V; Chow DC; Hu L; Sankaran B; Gilbert HF; Prasad BV; Palzkill T
    J Biol Chem; 2015 Apr; 290(16):10382-94. PubMed ID: 25713062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The catalytic efficiency (kcat/Km) of the class A beta-lactamase Toho-1 correlates with the thermal stability of its catalytic intermediate analog.
    Nitanai Y; Shimamura T; Uchiyama T; Ishii Y; Takehira M; Yutani K; Matsuzawa H; Miyano M
    Biochim Biophys Acta; 2010 Apr; 1804(4):684-91. PubMed ID: 19883800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural variants modify Klebsiella pneumoniae carbapenemase (KPC) acyl-enzyme conformational dynamics to extend antibiotic resistance.
    Tooke CL; Hinchliffe P; Bonomo RA; Schofield CJ; Mulholland AJ; Spencer J
    J Biol Chem; 2021; 296():100126. PubMed ID: 33257320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational events in cefotaximase extended-spectrum beta-lactamases of the CTX-M-1 cluster involved in ceftazidime resistance.
    Novais A; Cantón R; Coque TM; Moya A; Baquero F; Galán JC
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2377-82. PubMed ID: 18443114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis for the catalytic specificity of the CTX-M extended-spectrum β-lactamases.
    Adamski CJ; Cardenas AM; Brown NG; Horton LB; Sankaran B; Prasad BV; Gilbert HF; Palzkill T
    Biochemistry; 2015 Jan; 54(2):447-57. PubMed ID: 25489790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the global stabilizing substitution A77V and its role in the evolution of CTX-M β-lactamases.
    Patel MP; Fryszczyn BG; Palzkill T
    Antimicrob Agents Chemother; 2015 Nov; 59(11):6741-8. PubMed ID: 26282414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and dynamics of CTX-M enzymes reveal insights into substrate accommodation by extended-spectrum beta-lactamases.
    Delmas J; Chen Y; Prati F; Robin F; Shoichet BK; Bonnet R
    J Mol Biol; 2008 Jan; 375(1):192-201. PubMed ID: 17999931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel extended-spectrum beta-lactamase CTX-M-23 with a P167T substitution in the active-site omega loop associated with ceftazidime resistance.
    Stürenburg E; Kühn A; Mack D; Laufs R
    J Antimicrob Chemother; 2004 Aug; 54(2):406-9. PubMed ID: 15201232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New mutations in ADC-type β-lactamases from Acinetobacter spp. affect cefoxitin and ceftazidime hydrolysis.
    Pérez A; Pérez-Llarena FJ; García P; Kerff F; Beceiro A; Galleni M; Bou G
    J Antimicrob Chemother; 2014 Sep; 69(9):2407-11. PubMed ID: 24845871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic effects of functionally distinct substitutions in β-lactamase variants shed light on the evolution of bacterial drug resistance.
    Patel MP; Hu L; Brown CA; Sun Z; Adamski CJ; Stojanoski V; Sankaran B; Prasad BVV; Palzkill T
    J Biol Chem; 2018 Nov; 293(46):17971-17984. PubMed ID: 30275013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the inhibitor-resistant M69V substitution on the structures and populations of trans-enamine beta-lactamase intermediates.
    Totir MA; Padayatti PS; Helfand MS; Carey MP; Bonomo RA; Carey PR; van den Akker F
    Biochemistry; 2006 Oct; 45(39):11895-904. PubMed ID: 17002290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deciphering the Evolution of Cephalosporin Resistance to Ceftolozane-Tazobactam in Pseudomonas aeruginosa.
    Barnes MD; Taracila MA; Rutter JD; Bethel CR; Galdadas I; Hujer AM; Caselli E; Prati F; Dekker JP; Papp-Wallace KM; Haider S; Bonomo RA
    mBio; 2018 Dec; 9(6):. PubMed ID: 30538183
    [No Abstract]   [Full Text] [Related]  

  • 15. A drug-resistant β-lactamase variant changes the conformation of its active-site proton shuttle to alter substrate specificity and inhibitor potency.
    Soeung V; Lu S; Hu L; Judge A; Sankaran B; Prasad BVV; Palzkill T
    J Biol Chem; 2020 Dec; 295(52):18239-18255. PubMed ID: 33109613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Reaction Mechanism of Metallo-β-Lactamases Is Tuned by the Conformation of an Active-Site Mobile Loop.
    Palacios AR; Mojica MF; Giannini E; Taracila MA; Bethel CR; Alzari PM; Otero LH; Klinke S; Llarrull LI; Bonomo RA; Vila AJ
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30348667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the role of a conserved class A residue in the Ω-Loop of KPC-2 β-lactamase: a mechanism for ceftazidime hydrolysis.
    Levitt PS; Papp-Wallace KM; Taracila MA; Hujer AM; Winkler ML; Smith KM; Xu Y; Harris ME; Bonomo RA
    J Biol Chem; 2012 Sep; 287(38):31783-93. PubMed ID: 22843686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro selection of variants resistant to beta-lactams plus beta-lactamase inhibitors in CTX-M beta-lactamases: predicting the in vivo scenario?
    Ripoll A; Baquero F; Novais A; Rodríguez-Domínguez MJ; Turrientes MC; Cantón R; Galán JC
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4530-6. PubMed ID: 21788458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and Kinetic Insights into the "Ceftazidimase" Behavior of the Extended-Spectrum β-Lactamase CTX-M-96.
    Ghiglione B; Rodríguez MM; Herman R; Curto L; Dropa M; Bouillenne F; Kerff F; Galleni M; Charlier P; Gutkind G; Sauvage E; Power P
    Biochemistry; 2015 Aug; 54(32):5072-82. PubMed ID: 26228623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structures of ceftazidime and its transition-state analogue in complex with AmpC beta-lactamase: implications for resistance mutations and inhibitor design.
    Powers RA; Caselli E; Focia PJ; Prati F; Shoichet BK
    Biochemistry; 2001 Aug; 40(31):9207-14. PubMed ID: 11478888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.